Assessing How MIDD Can Support Early Clinical Decision Making & Accelerated Approval for Novel Modalities
- Learn how MIDD supported early clinical decision-making and accelerated development timelines for different modalities`
- Understand modeling strategies that helped define safe, effective doses earlier in the process
- How this ultimately combined with regulatory engagement and enabled faster progression to approval